vs

Side-by-side financial comparison of American Integrity Insurance Group, Inc. (AII) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

American Integrity Insurance Group, Inc. is the larger business by last-quarter revenue ($68.1M vs $34.2M, roughly 2.0× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 30.7%, a 28.2% gap on every dollar of revenue. American Integrity Insurance Group, Inc. produced more free cash flow last quarter ($133.2M vs $-11.3M).

American International Group, Inc. (AIG) is an American multinational finance and insurance corporation with operations in more than 80 countries and jurisdictions. As of 2023, AIG employed 25,200 people. The company operates through three core businesses: general insurance, life & retirement, and a standalone technology-enabled subsidiary. General Insurance includes Commercial, Personal Insurance, U.S. and International field operations. Life & Retirement includes Group Retirement, Individua...

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

AII vs DTIL — Head-to-Head

Bigger by revenue
AII
AII
2.0× larger
AII
$68.1M
$34.2M
DTIL
Higher net margin
DTIL
DTIL
28.2% more per $
DTIL
58.9%
30.7%
AII
More free cash flow
AII
AII
$144.4M more FCF
AII
$133.2M
$-11.3M
DTIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AII
AII
DTIL
DTIL
Revenue
$68.1M
$34.2M
Net Profit
$20.9M
$20.1M
Gross Margin
Operating Margin
43.0%
36.6%
Net Margin
30.7%
58.9%
Revenue YoY
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$0.58
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AII
AII
DTIL
DTIL
Q4 25
$68.1M
$34.2M
Q3 25
$62.0M
$13.0K
Q2 25
$74.5M
$18.0K
Q1 25
$71.9M
$29.0K
Q4 24
$638.0K
Q3 24
$576.0K
Q2 24
$49.9M
Q1 24
$17.6M
Net Profit
AII
AII
DTIL
DTIL
Q4 25
$20.9M
$20.1M
Q3 25
$13.2M
$-21.8M
Q2 25
$27.5M
$-23.5M
Q1 25
$38.1M
$-20.6M
Q4 24
Q3 24
$-16.4M
Q2 24
$32.7M
Q1 24
$8.6M
Operating Margin
AII
AII
DTIL
DTIL
Q4 25
43.0%
36.6%
Q3 25
30.3%
-158976.9%
Q2 25
32.3%
-121538.9%
Q1 25
59.7%
-76248.3%
Q4 24
Q3 24
-3693.6%
Q2 24
48.4%
Q1 24
-23.8%
Net Margin
AII
AII
DTIL
DTIL
Q4 25
30.7%
58.9%
Q3 25
21.2%
-167476.9%
Q2 25
36.9%
-130666.7%
Q1 25
53.0%
-70913.8%
Q4 24
Q3 24
-2851.6%
Q2 24
65.6%
Q1 24
48.8%
EPS (diluted)
AII
AII
DTIL
DTIL
Q4 25
$0.58
$2.62
Q3 25
$0.67
$-1.84
Q2 25
$1.62
$-2.13
Q1 25
$2.78
$-2.21
Q4 24
Q3 24
$-2.25
Q2 24
$4.67
Q1 24
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AII
AII
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$222.0M
$115.6M
Total DebtLower is stronger
$618.0K
Stockholders' EquityBook value
$337.0M
$92.2M
Total Assets
$1.2B
$154.4M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AII
AII
DTIL
DTIL
Q4 25
$222.0M
$115.6M
Q3 25
$171.9M
$44.9M
Q2 25
$259.6M
$62.2M
Q1 25
$236.4M
$77.2M
Q4 24
$86.3M
Q3 24
$101.2M
Q2 24
$123.6M
Q1 24
$137.8M
Total Debt
AII
AII
DTIL
DTIL
Q4 25
$618.0K
Q3 25
$721.0K
Q2 25
$824.0K
Q1 25
$926.0K
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AII
AII
DTIL
DTIL
Q4 25
$337.0M
$92.2M
Q3 25
$315.9M
$16.6M
Q2 25
$301.9M
$34.1M
Q1 25
$186.1M
$49.3M
Q4 24
$56.4M
Q3 24
$64.9M
Q2 24
$74.7M
Q1 24
$37.2M
Total Assets
AII
AII
DTIL
DTIL
Q4 25
$1.2B
$154.4M
Q3 25
$1.4B
$93.5M
Q2 25
$1.6B
$108.9M
Q1 25
$1.1B
$124.4M
Q4 24
$136.4M
Q3 24
$153.3M
Q2 24
$165.8M
Q1 24
$184.7M
Debt / Equity
AII
AII
DTIL
DTIL
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AII
AII
DTIL
DTIL
Operating Cash FlowLast quarter
$138.2M
$-11.3M
Free Cash FlowOCF − Capex
$133.2M
$-11.3M
FCF MarginFCF / Revenue
195.6%
-32.9%
Capex IntensityCapex / Revenue
7.4%
0.1%
Cash ConversionOCF / Net Profit
6.62×
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$216.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AII
AII
DTIL
DTIL
Q4 25
$138.2M
$-11.3M
Q3 25
$-7.5M
$-15.3M
Q2 25
$27.4M
$-20.3M
Q1 25
$68.1M
$-19.1M
Q4 24
$-58.4M
Q3 24
$-5.9M
Q2 24
$-14.9M
Q1 24
$-19.0M
Free Cash Flow
AII
AII
DTIL
DTIL
Q4 25
$133.2M
$-11.3M
Q3 25
$-11.9M
Q2 25
$26.9M
$-20.3M
Q1 25
$68.0M
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
AII
AII
DTIL
DTIL
Q4 25
195.6%
-32.9%
Q3 25
-19.2%
Q2 25
36.1%
-112627.8%
Q1 25
94.6%
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
AII
AII
DTIL
DTIL
Q4 25
7.4%
0.1%
Q3 25
7.2%
0.0%
Q2 25
0.6%
11.1%
Q1 25
0.2%
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
AII
AII
DTIL
DTIL
Q4 25
6.62×
-0.56×
Q3 25
-0.57×
Q2 25
1.00×
Q1 25
1.79×
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons